Arkolith/Insider Trading/TNGX/Form 4

TRV GP IV, LLC

10% OwnerTango Therapeutics, Inc. (TNGX) · full profile →Form 4 · filed Sep 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.1M
Net Open-Market Flow
-$5.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 8, 2025Sell(S)86K$7.04$609K14.7M
Sep 5, 2025Sell(S)643K$7.00$4.5M14.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-199177) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML